LEO Pharma A/S

Denmark

1 June 2019 - 31 May 2020

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for LEO Pharma A/S published between 1 June 2019 - 31 May 2020 which are tracked by the Nature Index.

Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

Count Share
2 0.10

Outputs by subject (Share)

Subject Count Share
Life Sciences 2 0.10

Top articles by Altmetric score in current window

Article has an altmetric score of 168

Blood natural killer cell deficiency reveals an immunotherapy strategy for atopic dermatitis

Science Translational Medicine

2020-02-26

Article has an altmetric score of 49

Distinct immune phenotypes in infants developing asthma during childhood

Science Translational Medicine

2020-02-05

1 June 2019 - 31 May 2020

International vs. domestic collaboration by Share

  • 39.38% Domestic
  • 60.62% International

Note: Hover over the graph to view the percentage of collaboration.

Top 10 domestic collaborators by Share (4 total)

  • LEO Pharma A/S, Denmark
  • Domestic institution
  1. University of Copenhagen (UCPH), Denmark (0.32)
    0.07
    0.25
  2. Gentofte University Hospital, Denmark (0.30)
    0.07
    0.23
  3. Herlev University Hospital, Denmark (0.30)
    0.07
    0.23
  4. Technical University of Denmark (DTU), Denmark (0.22)
    0.07
    0.15

Top 10 international collaborators by Share (13 total)

  • LEO Pharma A/S, Denmark
  • Foreign institution
  1. Washington University in St. Louis (WUSTL), United States of America (USA) (0.89)
    0.04
    0.85
  2. University of Giessen and Marburg Lung Center (UGMLC), Germany (0.13)
    0.07
    0.07
  3. Giessen University (JLU), Germany (0.08)
    0.07
    0.02
  4. Max Planck Society, Germany (0.08)
    0.07
    0.02
  5. Philipps University of Marburg (Uni Marburg), Germany (0.08)
    0.07
    0.02
  6. The German Center for Lung Research (DZL), Germany (0.08)
    0.07
    0.02
  7. The Ohio State University (OSU), United States of America (USA) (0.07)
    0.04
    0.04
  8. University of Pennsylvania (Penn), United States of America (USA) (0.07)
    0.04
    0.04
  9. Centre d’Immunologie de Marseille-Luminy (CIML), France (0.06)
    0.04
    0.02
  10. Innate Pharma S.A., France (0.06)
    0.04
    0.02

Note: Collaboration is determined by the fractional count (Share), which is listed in parentheses.

LEO Pharma A/S
Creative Commons License

Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Return to institution outputs

Except where otherwise noted © 2020 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER